Please assess the completion status of the following clinical trial:

Trial Title: Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: OTHER
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~CASES are those who:~* Survived at least 100 days post-hematopoietic stem cell transplantation (HSCT).~* Developed an SMN after that time point.~* And received TBI as part of the preparative regimen.~CONTROLS are randomly selected:~* In a 4:1 ratio to cases from the same cohort of 100 day + survivors of HSCT who received TBI.~* Controls will be matched to the cases by race and primary diagnosis.~* In addition, they must have survived for at least the elapsed time between the case's HSCT and the secondary cancer, without development of an SMN.~* We are matching on primary diagnosis, as genotype or radiation sensitivity may predispose to specific primary cancers, as well as the SMNs.~* We are matching on race, as allele frequencies vary widely across ethnic groups.~Exclusion Criteria:~* Did not survive at least 100 days post-hematopoietic stem cell transplantation (HSCT).~* Did not develop an SMN after that time point.~* Did not receive TBI as part of the preparative regimen.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).